abstract no. 254 ee: kawasaki disease: cta and mri/mra findings in coronary and non-coronary...

1
Percutaneous intervertebral disc decompression and ablative techniques METHOD DEFINITION SUCCESS RATE COMPLICATION RATE Automated Percutaneous Lumbar Discectomy a pneumatically driven, suction- cutting probe within a cannula, removes disc material anterior to the herniation. 75% 0-9% Percutaneous Laser Decompression laser energy vaporizes part of nucleus pulposus 63-89% 0.5-1% Intradiscal electrothermal therapy a thermal resistive coil coagulates the disc tissue with radiant heat 64-75% O.8% Intervertebral Disc Nucleoplasty non-heat driven process where plasma energy causes molecular dissociation and dissolves part of nucleus pulposus creating a series of intradiscal channels 79% 0.5% Percutaneous disc decompression nuclear material extraction is achieved with a mechanical high rotation per minute device with spiral tips 60-85% 0.5% Ozon therapy ozon therapy results in breakdown of nucleus pulposus with rapid disappearance of herniated material 70-78% 0.5% Discogel gelified ethanol causes dehydration of nucleus pulposus 91.4% 0.5% References: Kelekis AD, Somon T, Yilmaz H, Bize P, Brountzos EN, Lovblad K, Ruefenacht D, Martin JB. Inter- ventional spine procedures. Eur J Radiol 2005; 55:362–383. Abstract No. 253 A phase III, open-label study of tenecteplase for im- provement of hemodialysis catheter function: TROPICS 4 S. Fishbane 1 , S.L. Milligan 2 , K.D. Lempert 3 , J.E. Hertel 4 , J.B. Wetmore 5 , M.J. Oliver 6 , M. Blaney 7 , B. Gillespie 8 , J. Jacobs 7 , S. Begelman 7 ; 1 Winthrop University Hospital, Mineola, NY; 2 Nephrology Inc., Mishawaka, IN; 3 Pro- Medica Health System, Toledo, OH; 4 Kidney Care Associ- ates, Augusta, GA; 5 University of Kansas Medical Center, Kansas City, KS; 6 Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 7 Genentech, Inc., South San Fran- cisco, CA; 8 Quintiles, Inc., Morrisville, NC. Purpose: To determine the safety and efficacy of tenect- eplase, a thrombolytic, for the treatment of dysfunctional hemodialysis (HD) catheters. Materials and Methods: Patients with cuffed, tunneled HD catheters and blood flow rate (BFR) 300 mL/min at an arterial pressure of -240 to -280 mmHg received 2 mg/2 mL of open-label tenecteplase in each lumen for a 1-hour int- racatheter dwell. Treatment success was defined as BFR 300 mL/min with a 25 mL/min increase from baseline BFR, without line reversal, 30 minutes prior to and at the end of HD. Patients without treatment success at the end of the initial visit received another 2 mg of tenecteplase for an extended-dwell period of up to 72 hours. The primary efficacy endpoint was the proportion of patients with treat- ment success at the first HD visit. The incidence of all adverse events (AEs), including targeted AEs (intracranial hemorrhage [ICH], major bleeding, embolic events, throm- bosis, catheter-related bloodstream infection [CRBSI], and catheter-related complications) was recorded from initial tenecteplase administration through the second HD session after final tenecteplase exposure. Results: Tenecteplase was administered to 223 patients (mean age, 61 years; range, 16-97 years). Following 1-hour-dwell tenecteplase, 76 patients (34%; 95% confidence interval [CI], 28%-40%) had treatment success, with a mean (standard de- viation [SD]) increase from baseline BFR of 82 (124) mL/min. Of the 116 patients who received extended-dwell tenecteplase, 57 (49%; 95% CI, 40%-58%) had treatment success at the end of the next HD session, with a mean (SD) increase from baseline BFR of 117 (140) mL/min. Five CRBSIs and one thrombosis were reported, all of which resolved with treat- ment. There were no reports of ICH, major bleeding, or em- bolic events. Conclusion: Tenecteplase administered as a 1-hour dwell or 1-hour dwell followed by an extended dwell was associated with improved HD catheter function, as measured by BFR. The safety profile of intracatheter tenecteplase was favor- able, with a low incidence of targeted AEs. Abstract No. 254 EE Kawasaki disease: CTA and MRI/MRA findings in cor- onary and non-coronary arteries M.K. Ford, P. Liu; University of Michigan, Ann Arbor, MI. Learning Objectives: The objective of this educational ex- hibit is to review the current literature on Kawasaki disease and to demonstrate its vascular findings and their various consequences seen on CTA and MRI/MRA. Background: Kawasaki disease is a self-limiting vasculitis almost always seen in young children that affects predomi- nantly mid-sized arteries. As there is no laboratory test for the disease, the diagnosis is based on clinical symptoms combined with physical examination findings, including mucocutaneous abnormalities and lymph node enlargement. The most serious and well known sequella are due to coronary artery aneuryms. However, aneurysms are also seen in other mid-sized arteries throughout the body. The identification and characterization of these lesser known aneurysms is important to facilitate appro- priate follow-up and treatment when necessary. In the past, echocardiography and angiography were the imaging modali- ties of choice. While echocardiography is still most commonly used to follow coronary artery abnormalities, CTA and MRI/ MRA are becoming more popular in evaluating coronary and non-coronary artery aneurysms. Clinical Findings/Procedure Details: Selected CTA and MRI/MRA cases of patients with a history of Kawasaki disease are presented. Findings including aneurysmal dila- tation of coronary, carotid, vertebral, axillary, iliac, abdom- inal, and extremity arteries are demonstrated. Included are findings illustrating acute and long-term complications in patients managed expectantly and operatively. The current relevant literature regarding Kawasaki disease is reviewed. Conclusion and/or Teaching Points: After viewing the exhibit, radiologists should be able to recognize and char- acterize on CTA and MRI/MRA the following in patients with a history of Kawasaki disease: 1. Typical and atypical findings in coronary arteries and their complications. 2. Typical and atypical findings in non-coronary arteries and their complications. 3. Long-term follow-up appearance of aneurysms that have been managed either expectantly or operatively. Abstract No. 255 The bumper stitch: A better way to secure tubes? A. Fu, A. Cohen, S. Trerotola; University of Pennsylvania Medical Center, Philadelphia, PA. Purpose: Drainage tube dislodgement is a common compli- cation of a commonly performed procedure. Dislodgement of drains secured using the traditional “air knot” technique (in which a suture in placed into the skin near the drain exit site and knotted, with the free ends of the knot wrapped around the tube and again tied to secure it) usually occurs due to suture erosion through the skin, requiring additional visits for resu- S97 POSTER SESSIONS

Upload: p

Post on 01-Jan-2017

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Abstract No. 254 EE: Kawasaki disease: CTA and MRI/MRA findings in coronary and non-coronary arteries

PO

ST

ER

SE

SS

ION

S

Percutaneous intervertebral disc decompression and ablative techniquesMETHOD DEFINITION SUCCESS

RATECOMPLICATIONRATE

AutomatedPercutaneousLumbarDiscectomy

a pneumatically driven, suction-cutting probe within a cannula,removes disc material anteriorto the herniation.

75% 0-9%

Percutaneous LaserDecompression

laser energy vaporizes part ofnucleus pulposus

63-89% 0.5-1%

Intradiscalelectrothermaltherapy

a thermal resistive coilcoagulates the disc tissue withradiant heat

64-75% O.8%

Intervertebral DiscNucleoplasty

non-heat driven process whereplasma energy causesmolecular dissociation anddissolves part of nucleuspulposus creating a series ofintradiscal channels

79% �0.5%

Percutaneous discdecompression

nuclear material extraction isachieved with a mechanicalhigh rotation per minute devicewith spiral tips

60-85% �0.5%

Ozon therapy ozon therapy results inbreakdown of nucleus pulposuswith rapid disappearance ofherniated material

70-78% �0.5%

Discogel gelified ethanol causesdehydration of nucleuspulposus

91.4% �0.5%

References: Kelekis AD, Somon T, Yilmaz H, Bize P,Brountzos EN, Lovblad K, Ruefenacht D, Martin JB. Inter-ventional spine procedures. Eur J Radiol 2005; 55:362–383.

Abstract No. 253

A phase III, open-label study of tenecteplase for im-provement of hemodialysis catheter function: TROPICS4S. Fishbane1, S.L. Milligan2, K.D. Lempert3, J.E. Hertel4,J.B. Wetmore5, M.J. Oliver6, M. Blaney7, B. Gillespie8,J. Jacobs7, S. Begelman7; 1Winthrop University Hospital,Mineola, NY; 2Nephrology Inc., Mishawaka, IN; 3Pro-Medica Health System, Toledo, OH; 4Kidney Care Associ-ates, Augusta, GA; 5University of Kansas Medical Center,Kansas City, KS; 6Sunnybrook Health Sciences Centre,Toronto, ON, Canada; 7Genentech, Inc., South San Fran-cisco, CA; 8Quintiles, Inc., Morrisville, NC.

Purpose: To determine the safety and efficacy of tenect-eplase, a thrombolytic, for the treatment of dysfunctionalhemodialysis (HD) catheters.

Materials and Methods: Patients with cuffed, tunneled HDcatheters and blood flow rate (BFR) �300 mL/min at anarterial pressure of -240 to -280 mmHg received 2 mg/2 mLof open-label tenecteplase in each lumen for a 1-hour int-racatheter dwell. Treatment success was defined as BFR�300 mL/min with a �25 mL/min increase from baselineBFR, without line reversal, 30 minutes prior to and at theend of HD. Patients without treatment success at the end ofthe initial visit received another 2 mg of tenecteplase for anextended-dwell period of up to 72 hours. The primaryefficacy endpoint was the proportion of patients with treat-ment success at the first HD visit. The incidence of alladverse events (AEs), including targeted AEs (intracranialhemorrhage [ICH], major bleeding, embolic events, throm-bosis, catheter-related bloodstream infection [CRBSI], andcatheter-related complications) was recorded from initialtenecteplase administration through the second HD sessionafter final tenecteplase exposure.

Results: Tenecteplase was administered to 223 patients (meanage, 61 years; range, 16-97 years). Following 1-hour-dwelltenecteplase, 76 patients (34%; 95% confidence interval [CI],28%-40%) had treatment success, with a mean (standard de-viation [SD]) increase from baseline BFR of 82 (124) mL/min.Of the 116 patients who received extended-dwell tenecteplase,57 (49%; 95% CI, 40%-58%) had treatment success at the endof the next HD session, with a mean (SD) increase frombaseline BFR of 117 (140) mL/min. Five CRBSIs and one

thrombosis were reported, all of which resolved with treat-

ment. There were no reports of ICH, major bleeding, or em-bolic events.

Conclusion: Tenecteplase administered as a 1-hour dwell or1-hour dwell followed by an extended dwell was associatedwith improved HD catheter function, as measured by BFR.The safety profile of intracatheter tenecteplase was favor-able, with a low incidence of targeted AEs.

Abstract No. 254 EE

Kawasaki disease: CTA and MRI/MRA findings in cor-onary and non-coronary arteriesM.K. Ford, P. Liu; University of Michigan, Ann Arbor, MI.

Learning Objectives: The objective of this educational ex-hibit is to review the current literature on Kawasaki diseaseand to demonstrate its vascular findings and their variousconsequences seen on CTA and MRI/MRA.

Background: Kawasaki disease is a self-limiting vasculitisalmost always seen in young children that affects predomi-nantly mid-sized arteries. As there is no laboratory test for thedisease, the diagnosis is based on clinical symptoms combinedwith physical examination findings, including mucocutaneousabnormalities and lymph node enlargement. The most seriousand well known sequella are due to coronary artery aneuryms.However, aneurysms are also seen in other mid-sized arteriesthroughout the body. The identification and characterization ofthese lesser known aneurysms is important to facilitate appro-priate follow-up and treatment when necessary. In the past,echocardiography and angiography were the imaging modali-ties of choice. While echocardiography is still most commonlyused to follow coronary artery abnormalities, CTA and MRI/MRA are becoming more popular in evaluating coronary andnon-coronary artery aneurysms.

Clinical Findings/Procedure Details: Selected CTA andMRI/MRA cases of patients with a history of Kawasakidisease are presented. Findings including aneurysmal dila-tation of coronary, carotid, vertebral, axillary, iliac, abdom-inal, and extremity arteries are demonstrated. Included arefindings illustrating acute and long-term complications inpatients managed expectantly and operatively. The currentrelevant literature regarding Kawasaki disease is reviewed.

Conclusion and/or Teaching Points: After viewing theexhibit, radiologists should be able to recognize and char-acterize on CTA and MRI/MRA the following in patientswith a history of Kawasaki disease:1. Typical and atypical findings in coronary arteries andtheir complications.2. Typical and atypical findings in non-coronary arteries andtheir complications.3. Long-term follow-up appearance of aneurysms that havebeen managed either expectantly or operatively.

Abstract No. 255

The bumper stitch: A better way to secure tubes?A. Fu, A. Cohen, S. Trerotola; University of PennsylvaniaMedical Center, Philadelphia, PA.

Purpose: Drainage tube dislodgement is a common compli-cation of a commonly performed procedure. Dislodgement ofdrains secured using the traditional “air knot” technique (inwhich a suture in placed into the skin near the drain exit siteand knotted, with the free ends of the knot wrapped around thetube and again tied to secure it) usually occurs due to suture

erosion through the skin, requiring additional visits for resu-

S97